A retrospective study of the clinical benefit from acetylsalicylic acid desensitization in patients with nasal polyposis and asthma

被引:19
作者
Ibrahim, Christine [1 ]
Singh, Kulraj [1 ]
Tsai, Gina [1 ,2 ]
Huang, David [1 ,2 ]
Mazza, Jorge [1 ,2 ]
Rotenberg, Brian [1 ,3 ]
Kim, Harold [1 ,2 ]
Moote, David William [1 ,2 ]
机构
[1] Schulich Sch Med & Dent, London, ON, Canada
[2] Dept Allergy & Immunol, London, ON, Canada
[3] Dept Otolaryngol, London, ON, Canada
关键词
Aspirin desensitization; Nasal polyposis; Rhinosinusitis; Asthma; Aspirin-exacerbated respiratory disease; ASPIRIN DESENSITIZATION; INTOLERANCE; CHALLENGES; OUTCOMES;
D O I
10.1186/s13223-014-0064-7
中图分类号
R392 [医学免疫学];
学科分类号
100108 [医学免疫学];
摘要
Background: Aspirin-exacerbated respiratory disease (AERD), also known as Samter's triad, is a clinical syndrome which consists of aspirin (ASA) intolerance, chronic rhinosinusitis with nasal polyposis, and intrinsic bronchial asthma (Press Med 119: 48-51, 1922). ASA challenge is the gold standard for diagnosing AERD (Curr Allergy Asthma 9: 155-163, 2009). The practice of ASA challenge and desensitization in Canada is infrequently utilized, which may explain its omission as a viable therapeutic option in the latest Canadian clinical practice guidelines for acute and chronic rhinosinusitis (AACI 7: 1-38, 2011). Methods: This retrospective study assessed 111 patients who underwent ASA desensitization in the Allergy and Immunology clinic at St. Joseph's Healthcare (SJHC) in London, Ontario. The mean age was 50.7 years, and 52.5% (n = 58) were male. Sixty-one percent (n = 68) claimed prior, significant reactions to ASA, and all patients had features of AERD. Results: Seventy-three percent (n = 81) claimed symptom improvement after achieving maintenance dosing on the desensitization protocol. Of this population, 21.6% (n = 24) improved in all 3 areas of interest (sense of taste or smell, upper respiratory symptoms and lower respiratory symptoms). Twenty-six percent (n = 29) had adverse effects, mostly in the way of gastrointestinal upset, but no severe adverse events were seen. Conclusions: ASA desensitization helps improve symptoms in patients with AERD. Further, it allows patients to tolerate additional ASA and other non-steroidal anti-inflammatories (NSAIDs) when needed for supplemental analgesia or for cardio-protection. This is of particular benefit in those who require these medications for improved quality of life, and for reduced morbidity and mortality, such as those with cardiovascular disease or chronic pain. There should be further studies conducted in Canada as well as consideration for ASA desensitization to be included in the next clinical practice guidelines.
引用
收藏
页数:6
相关论文
共 16 条
[1]
Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease [J].
Berges-Gimeno, MP ;
Simon, RA ;
Stevenson, DD .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 90 (03) :338-341
[2]
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease [J].
Berges-Gimeno, MP ;
Simon, RA ;
Stevenson, DD .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (01) :180-186
[3]
Long-term Sinonasal Outcomes of Aspirin Desensitization in Aspirin Exacerbated Respiratory Disease [J].
Cho, Kyu-Sup ;
Soudry, Ethan ;
Psaltis, Alkis J. ;
Nadeau, Kari C. ;
McGhee, Sean A. ;
Nayak, Jayakar V. ;
Hwang, Peter H. .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2014, 151 (04) :575-581
[4]
Canadian clinical practice guidelines for acute and chronic rhinosinusitis [J].
Desrosiers, Martin ;
Evans, Gerald A. ;
Keith, Paul K. ;
Wright, Erin D. ;
Kaplan, Alan ;
Bouchard, Jacques ;
Ciavarella, Anthony ;
Doyle, Patrick W. ;
Javer, Amin R. ;
Leith, Eric S. ;
Mukherji, Atreyi ;
Schellenberg, R. Robert ;
Small, Peter ;
Witterick, Ian J. .
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2011, 7
[5]
Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis [J].
Dursun, Adile Berna ;
Woessner, Katharine A. ;
Simon, Ronald A. ;
Karasoy, Durdu ;
Stevenson, Donald D. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (05) :420-425
[6]
Fokkens W., 2007, RHINOLOGY, V45, P1
[7]
Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease [J].
Lee, Jennifer Y. ;
Simon, Ronald A. ;
Stevenson, Donald D. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) :157-164
[8]
Aspirin-Exacerbated Respiratory Disease: Evaluation and Management [J].
Lee, Rachel U. ;
Stevenson, Donald D. .
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2011, 3 (01) :3-10
[9]
Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements [J].
Pfaar, Oliver ;
Klimek, Ludger .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 6 (03) :161-166
[10]
INTOLERANCE TO ASPIRIN - CLINICAL STUDIES AND CONSIDERATION OF ITS PATHOGENESIS [J].
SAMTER, M ;
BEERS, RF .
ANNALS OF INTERNAL MEDICINE, 1968, 68 (05) :975-+